215 related articles for article (PubMed ID: 9792545)
1. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.
Fernández-Real JM; Broch M; Ricart W; Casamitjana R; Gutierrez C; Vendrell J; Richart C
Diabetes; 1998 Nov; 47(11):1757-62. PubMed ID: 9792545
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy.
Fernández-Real JM; Molina A; Broch M; Ricart W; Gutiérrez C; Casamitjana R; Vendrell J; Soler J; Gómez-Sáez JM
Diabetes; 1999 May; 48(5):1108-12. PubMed ID: 10331417
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of soluble tumor necrosis factor-alpha receptor 2 are linked to insulin resistance and glucose intolerance in children.
Gupta A; Ten S; Anhalt H
J Pediatr Endocrinol Metab; 2005 Jan; 18(1):75-82. PubMed ID: 15679072
[TBL] [Abstract][Full Text] [Related]
4. Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study.
Fernandez-Real JM; Pugeat M; Grasa M; Broch M; Vendrell J; Brun J; Ricart W
J Clin Endocrinol Metab; 2002 Oct; 87(10):4686-90. PubMed ID: 12364459
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma-soluble tumor necrosis factor-alpha receptor 2 level in lean nondiabetic offspring of type 2 diabetic subjects.
Straczkowski M; Kowalska I; Stepien A; Dzienis-Straczkowska S; Szelachowska M; Kinalska I
Diabetes Care; 2002 Oct; 25(10):1824-8. PubMed ID: 12351485
[TBL] [Abstract][Full Text] [Related]
6. Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance.
Dzienis-Straczkowska S; Straczkowski M; Szelachowska M; Stepien A; Kowalska I; Kinalska I
Diabetes Care; 2003 Mar; 26(3):875-80. PubMed ID: 12610052
[TBL] [Abstract][Full Text] [Related]
7. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system.
Straczkowski M; Dzienis-Straczkowska S; Stêpieñ A; Kowalska I; Szelachowska M; Kinalska I
J Clin Endocrinol Metab; 2002 Oct; 87(10):4602-6. PubMed ID: 12364441
[TBL] [Abstract][Full Text] [Related]
8. Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance.
Straczkowski M; Kowalska I; Dzienis-Straczkowska S; Stepién A; Skibińska E; Szelachowska M; Kinalska I
Eur J Endocrinol; 2001 Sep; 145(3):273-80. PubMed ID: 11517007
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of the soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subjects.
Fernández-Real JM; Gutiérrez C; Ricart W; Castiñeira MJ; Vendrell J; Richart C
Atherosclerosis; 1999 Oct; 146(2):321-7. PubMed ID: 10532687
[TBL] [Abstract][Full Text] [Related]
10. Smoking, fat mass and activation of the tumor necrosis factor-alpha pathway.
Fernandez-Real JM; Broch M; Vendrell J; Ricart W
Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1552-6. PubMed ID: 12975637
[TBL] [Abstract][Full Text] [Related]
11. Relationships between serum adiponectin and soluble TNF-α receptors and glucose and lipid oxidation in lean and obese subjects.
Adamska A; Nikołajuk A; Karczewska-Kupczewska M; Kowalska I; Otziomek E; Górska M; Strączkowski M
Acta Diabetol; 2012 Feb; 49(1):17-24. PubMed ID: 21234613
[TBL] [Abstract][Full Text] [Related]
12. Elevated soluble intercellular adhesion molecule-1 levels in obesity: relationship to insulin resistance and tumor necrosis factor-alpha system activity.
Straczkowski M; Lewczuk P; Dzienis-Straczkowska S; Kowalska I; Stepień A; Kinalska I
Metabolism; 2002 Jan; 51(1):75-8. PubMed ID: 11782876
[TBL] [Abstract][Full Text] [Related]
13. Plasma soluble tumour necrosis factor-alpha receptor 2 is elevated in obesity: specific contribution of visceral adiposity.
Cartier A; Côté M; Bergeron J; Alméras N; Tremblay A; Lemieux I; Després JP
Clin Endocrinol (Oxf); 2010 Mar; 72(3):349-57. PubMed ID: 19650780
[TBL] [Abstract][Full Text] [Related]
14. Novel interactions of adiponectin with the endocrine system and inflammatory parameters.
Fernández-Real JM; López-Bermejo A; Casamitjana R; Ricart W
J Clin Endocrinol Metab; 2003 Jun; 88(6):2714-8. PubMed ID: 12788878
[TBL] [Abstract][Full Text] [Related]
15. The insulin resistance syndrome and the binding capacity of cortisol binding globulin (CBG) in men and women.
Fernández-Real JM; Grasa M; Casamitjana R; Ricart W
Clin Endocrinol (Oxf); 2000 Jan; 52(1):93-9. PubMed ID: 10651759
[TBL] [Abstract][Full Text] [Related]
16. Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects.
Corica F; Allegra A; Corsonello A; Buemi M; Calapai G; Ruello A; Nicita Mauro V; Ceruso D
Int J Obes Relat Metab Disord; 1999 Apr; 23(4):355-60. PubMed ID: 10340812
[TBL] [Abstract][Full Text] [Related]
17. Contribution of skeletal muscle mass on sex differences in 2-hour plasma glucose levels after oral glucose load in Thai subjects with normal glucose tolerance.
Rattarasarn C; Leelawattana R; Soonthornpun S
Metabolism; 2010 Feb; 59(2):172-6. PubMed ID: 19765781
[TBL] [Abstract][Full Text] [Related]
18. Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus.
González-Clemente JM; Mauricio D; Richart C; Broch M; Caixàs A; Megia A; Giménez-Palop O; Simón I; Martínez-Riquelme A; Giménez-Pérez G; Vendrell J
Clin Endocrinol (Oxf); 2005 Nov; 63(5):525-9. PubMed ID: 16268804
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of soluble tumor necrosis factor-alpha receptors are related to total and LDL-cholesterol in lean, but not in obese subjects.
Straczkowski M; Kowalska I; Nikolajuk A; Adamska A; Karolczuk-Zarachowicz M; Karczewska-Kupczewska M; Kozlowska A; Gorska M
Cardiovasc Diabetol; 2006 Jun; 5():14. PubMed ID: 16803616
[TBL] [Abstract][Full Text] [Related]
20. Lower cortisol levels after oral glucose in subjects with insulin resistance and abdominal obesity.
Fernández-Real JM; Ricart W; Casamitjana R
Clin Endocrinol (Oxf); 1997 Nov; 47(5):583-8. PubMed ID: 9425398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
